Anchang Liu

1.1k total citations
49 papers, 877 citations indexed

About

Anchang Liu is a scholar working on Molecular Biology, Biomaterials and Molecular Medicine. According to data from OpenAlex, Anchang Liu has authored 49 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Biomaterials and 7 papers in Molecular Medicine. Recurrent topics in Anchang Liu's work include Nanoparticle-Based Drug Delivery (7 papers), Curcumin's Biomedical Applications (6 papers) and Nanoplatforms for cancer theranostics (5 papers). Anchang Liu is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Curcumin's Biomedical Applications (6 papers) and Nanoplatforms for cancer theranostics (5 papers). Anchang Liu collaborates with scholars based in China, Belarus and Finland. Anchang Liu's co-authors include Li-Xia Zhao, Hong‐Xiang Lou, Guangxi Zhai, Peihong Fan, Yanxiao Xiang, Yuan Gao, Jianbo Ji, Xiaoye Yang, Hua Zhao and Yuguo Chen and has published in prestigious journals such as Analytical Chemistry, Chemical Engineering Journal and The FASEB Journal.

In The Last Decade

Anchang Liu

48 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anchang Liu China 16 346 276 160 135 84 49 877
Lucia Ruxandra Tefas Romania 16 228 0.7× 205 0.7× 239 1.5× 167 1.2× 114 1.4× 28 763
Xiaowei Lu China 15 364 1.1× 125 0.5× 226 1.4× 87 0.6× 99 1.2× 39 916
Dezhong Sun China 5 240 0.7× 295 1.1× 73 0.5× 68 0.5× 29 0.3× 9 575
Huiyun Zhang China 18 430 1.2× 78 0.3× 190 1.2× 127 0.9× 114 1.4× 57 983
Raghu Ganugula United States 23 359 1.0× 159 0.6× 72 0.5× 100 0.7× 51 0.6× 46 1.1k
Feng Shi China 17 347 1.0× 103 0.4× 225 1.4× 231 1.7× 120 1.4× 55 992
Ziming Zhao China 21 374 1.1× 91 0.3× 333 2.1× 145 1.1× 218 2.6× 56 1.1k
Mehak Goel United States 8 365 1.1× 185 0.7× 113 0.7× 45 0.3× 51 0.6× 11 990
Rana Shafabakhsh Iran 21 783 2.3× 228 0.8× 115 0.7× 56 0.4× 70 0.8× 45 1.6k
Andreia Granja Portugal 14 260 0.8× 75 0.3× 221 1.4× 128 0.9× 171 2.0× 23 845

Countries citing papers authored by Anchang Liu

Since Specialization
Citations

This map shows the geographic impact of Anchang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anchang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anchang Liu more than expected).

Fields of papers citing papers by Anchang Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anchang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anchang Liu. The network helps show where Anchang Liu may publish in the future.

Co-authorship network of co-authors of Anchang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Anchang Liu. A scholar is included among the top collaborators of Anchang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anchang Liu. Anchang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Fangyuan, et al.. (2025). Synthesis, biological and pharmacokinetic characterization of a novel leucine ureido derivative as a multi-target anticancer agent. RSC Advances. 15(6). 4348–4355. 1 indexed citations
2.
Liang, Dong, Yu Chen, Lan Yan, et al.. (2025). Discovery of Environment-Sensitive Near Infrared SHP2-Targeting Fluorescent Ligands for Living Cells and Tissue Section Imaging. Analytical Chemistry. 97(23). 12143–12154. 1 indexed citations
3.
Jia, Lejiao, Yue Liu, Ying Zhou, et al.. (2024). Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer. Journal of Nanobiotechnology. 22(1). 198–198. 9 indexed citations
4.
Xu, Jiangkang, Fenghua Wang, Lei Ye, et al.. (2023). Penetrating peptides: Applications in drug delivery. Journal of Drug Delivery Science and Technology. 84. 104475–104475. 14 indexed citations
5.
Wang, Rui, Yingying Li, Shan Gao, et al.. (2023). An active transport dual adaptive nanocarrier designed to overcome the corneal microenvironment for neovascularization therapy. Biomaterials Science. 12(2). 361–374. 2 indexed citations
6.
Wu, Di, et al.. (2023). Quality of life in ovarian cancer patients treated with bevacizumab: a meta-analysis. Expert Opinion on Drug Safety. 23(3). 269–276. 1 indexed citations
7.
Ma, Jie, et al.. (2023). Widely targeted metabolomics unveils baicalin-induced hippocampal metabolic alternations in a rat model of chronic unpredictable mild stress. Journal of Pharmaceutical and Biomedical Analysis. 237. 115766–115766.
8.
Li, Zejing, et al.. (2023). Active surveillance and clinical analysis of anaphylaxis based on the China Hospital Pharmacovigilance System. Frontiers in Pharmacology. 14. 1180685–1180685. 1 indexed citations
9.
Xu, Jiangkang, Xiaoye Yang, Jianbo Ji, et al.. (2021). RVG-functionalized reduction sensitive micelles for the effective accumulation of doxorubicin in brain. Journal of Nanobiotechnology. 19(1). 251–251. 25 indexed citations
10.
Gao, Yuan, et al.. (2021). Natural polymeric nanocarriers in malignant glioma drug delivery and targeting. Journal of drug targeting. 29(9). 960–973. 9 indexed citations
11.
Yu, Yan‐Hao, et al.. (2021). Analysis of pathogens, drug resistance, sensitive antibiotic treatment and risk factors of early-onset sepsis in very low birth weight infants.. PubMed. 13(11). 12939–12948. 2 indexed citations
12.
Liu, Min, et al.. (2021). Hollow Gold Nanoparticles Loaded with L-Buthionine-Sulfoximine as a Novel Nanomedicine for In Vitro Cancer Cell Therapy. Journal of Nanomaterials. 2021. 1–9. 7 indexed citations
13.
Yang, Bo, et al.. (2020). Unsupervised Optical Flow Estimation Based on Improved Feature Pyramid. Neural Processing Letters. 52(2). 1601–1612. 4 indexed citations
14.
Xiang, Yanxiao, Xinbing Wei, Pengchao Du, et al.. (2019). β‐Arrestin‐2‐ERK1/2 cPLA 2 α axis mediates TLR4 signaling to influence eicosanoid induction in ischemic brain. The FASEB Journal. 33(5). 6584–6595. 4 indexed citations
15.
Zhang, Xingzhen, et al.. (2018). The enhanced effect of tetrahydrocurcumin on radiosensitivity of glioma cells. Journal of Pharmacy and Pharmacology. 70(6). 749–759. 16 indexed citations
16.
Dou, Jinfeng, et al.. (2013). Advances in the formulations of non-injection administration of docetaxel. Journal of drug targeting. 22(2). 87–94. 12 indexed citations
17.
Jia, Lihui, et al.. (2011). Magnetostructural Correlation Study of a Novel Strong Antiferromagnetic Dimer Copper(II) Coordination Complex with Mono-Methyl Phthalate. Acta Physico-Chimica Sinica. 27(7). 1595–1599. 3 indexed citations
18.
Liu, Anchang, et al.. (2009). Study of Synthetic Process of Novel Neonicotinoid Dinotefuran. 31(2). 1 indexed citations
19.
Ehlers, Henrik, Anchang Liu, Heikki Räikkönen, et al.. (2009). Granule size control and targeting in pulsed spray fluid bed granulation. International Journal of Pharmaceutics. 377(1-2). 9–15. 27 indexed citations
20.
Liu, Anchang, Hong‐Xiang Lou, Li-Xia Zhao, & Peihong Fan. (2005). Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. Journal of Pharmaceutical and Biomedical Analysis. 40(3). 720–727. 215 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucia Ruxandra Tefas Breakdown of academic impact, for papers by Xiaowei Lu Breakdown of academic impact, for papers by Dezhong Sun Breakdown of academic impact, for papers by Huiyun Zhang Breakdown of academic impact, for papers by Raghu Ganugula Breakdown of academic impact, for papers by Feng Shi Breakdown of academic impact, for papers by Ziming Zhao Breakdown of academic impact, for papers by Mehak Goel Breakdown of academic impact, for papers by Rana Shafabakhsh Breakdown of academic impact, for papers by Andreia Granja
Rankless by CCL
2026